A qualitative study exploring patient motivations for screening for lung cancer

Joshua A. Roth, Lisa Carter-Harris, Susan Brandzel, Diana S.M. Buist, Karen J. Wernli

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background Low-dose computed tomography (LDCT) of the chest for lung cancer screening of heavy smokers was given a ‘B’ rating by the U.S. Preventive Services Task Force (USPSTF) in 2013, and gained widespread insurance coverage in the U.S. in 2015. Lung cancer screening has since had low uptake. However, for those that do choose to screen, little is known about patient motivations for completing screening in real-world practice. Objective To explore the motivations for screening-eligible patients to screen for lung cancer. Methods Semi-structured qualitative interviews were conducted with 20 LDCT screen-completed men and women who were members of an integrated mixed-model healthcare system in Washington State. From June to September 2015, participants were recruited and individual interviews performed about motivations to screen for lung cancer. Audio-recorded interviews were transcribed and analyzed using inductive content analysis by three investigators. Results Four primary themes emerged as motivations for completing LDCT lung cancer screening: 1) trust in the referring clinician; 2) early-detection benefit; 3) low or limited harm perception; and 4) friends or family with advanced cancer. Conclusion Participants in our study were primarily motivated to screen for lung cancer based on perceived benefit of early-detection, absence of safety concerns, and personal relationships. Our findings provide new insights about patient motivations to screen, and can potentially be used to improve lung cancer screening uptake and shared decision-making processes.

Original languageEnglish (US)
Article numbere0196758
JournalPLoS One
Volume13
Issue number7
DOIs
StatePublished - Jul 1 2018

Fingerprint

lung neoplasms
Motivation
Lung Neoplasms
Screening
screening
Early Detection of Cancer
Tomography
computed tomography
interviews
Interviews
dosage
Insurance
Insurance Coverage
insurance
chest
Advisory Committees
health services
Decision making
decision making
Decision Making

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Roth, J. A., Carter-Harris, L., Brandzel, S., Buist, D. S. M., & Wernli, K. J. (2018). A qualitative study exploring patient motivations for screening for lung cancer. PLoS One, 13(7), [e0196758]. https://doi.org/10.1371/journal.pone.0196758

A qualitative study exploring patient motivations for screening for lung cancer. / Roth, Joshua A.; Carter-Harris, Lisa; Brandzel, Susan; Buist, Diana S.M.; Wernli, Karen J.

In: PLoS One, Vol. 13, No. 7, e0196758, 01.07.2018.

Research output: Contribution to journalArticle

Roth, JA, Carter-Harris, L, Brandzel, S, Buist, DSM & Wernli, KJ 2018, 'A qualitative study exploring patient motivations for screening for lung cancer', PLoS One, vol. 13, no. 7, e0196758. https://doi.org/10.1371/journal.pone.0196758
Roth JA, Carter-Harris L, Brandzel S, Buist DSM, Wernli KJ. A qualitative study exploring patient motivations for screening for lung cancer. PLoS One. 2018 Jul 1;13(7). e0196758. https://doi.org/10.1371/journal.pone.0196758
Roth, Joshua A. ; Carter-Harris, Lisa ; Brandzel, Susan ; Buist, Diana S.M. ; Wernli, Karen J. / A qualitative study exploring patient motivations for screening for lung cancer. In: PLoS One. 2018 ; Vol. 13, No. 7.
@article{219cfecd41bb4bb78ea5b397880aaedc,
title = "A qualitative study exploring patient motivations for screening for lung cancer",
abstract = "Background Low-dose computed tomography (LDCT) of the chest for lung cancer screening of heavy smokers was given a ‘B’ rating by the U.S. Preventive Services Task Force (USPSTF) in 2013, and gained widespread insurance coverage in the U.S. in 2015. Lung cancer screening has since had low uptake. However, for those that do choose to screen, little is known about patient motivations for completing screening in real-world practice. Objective To explore the motivations for screening-eligible patients to screen for lung cancer. Methods Semi-structured qualitative interviews were conducted with 20 LDCT screen-completed men and women who were members of an integrated mixed-model healthcare system in Washington State. From June to September 2015, participants were recruited and individual interviews performed about motivations to screen for lung cancer. Audio-recorded interviews were transcribed and analyzed using inductive content analysis by three investigators. Results Four primary themes emerged as motivations for completing LDCT lung cancer screening: 1) trust in the referring clinician; 2) early-detection benefit; 3) low or limited harm perception; and 4) friends or family with advanced cancer. Conclusion Participants in our study were primarily motivated to screen for lung cancer based on perceived benefit of early-detection, absence of safety concerns, and personal relationships. Our findings provide new insights about patient motivations to screen, and can potentially be used to improve lung cancer screening uptake and shared decision-making processes.",
author = "Roth, {Joshua A.} and Lisa Carter-Harris and Susan Brandzel and Buist, {Diana S.M.} and Wernli, {Karen J.}",
year = "2018",
month = "7",
day = "1",
doi = "10.1371/journal.pone.0196758",
language = "English (US)",
volume = "13",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

TY - JOUR

T1 - A qualitative study exploring patient motivations for screening for lung cancer

AU - Roth, Joshua A.

AU - Carter-Harris, Lisa

AU - Brandzel, Susan

AU - Buist, Diana S.M.

AU - Wernli, Karen J.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Background Low-dose computed tomography (LDCT) of the chest for lung cancer screening of heavy smokers was given a ‘B’ rating by the U.S. Preventive Services Task Force (USPSTF) in 2013, and gained widespread insurance coverage in the U.S. in 2015. Lung cancer screening has since had low uptake. However, for those that do choose to screen, little is known about patient motivations for completing screening in real-world practice. Objective To explore the motivations for screening-eligible patients to screen for lung cancer. Methods Semi-structured qualitative interviews were conducted with 20 LDCT screen-completed men and women who were members of an integrated mixed-model healthcare system in Washington State. From June to September 2015, participants were recruited and individual interviews performed about motivations to screen for lung cancer. Audio-recorded interviews were transcribed and analyzed using inductive content analysis by three investigators. Results Four primary themes emerged as motivations for completing LDCT lung cancer screening: 1) trust in the referring clinician; 2) early-detection benefit; 3) low or limited harm perception; and 4) friends or family with advanced cancer. Conclusion Participants in our study were primarily motivated to screen for lung cancer based on perceived benefit of early-detection, absence of safety concerns, and personal relationships. Our findings provide new insights about patient motivations to screen, and can potentially be used to improve lung cancer screening uptake and shared decision-making processes.

AB - Background Low-dose computed tomography (LDCT) of the chest for lung cancer screening of heavy smokers was given a ‘B’ rating by the U.S. Preventive Services Task Force (USPSTF) in 2013, and gained widespread insurance coverage in the U.S. in 2015. Lung cancer screening has since had low uptake. However, for those that do choose to screen, little is known about patient motivations for completing screening in real-world practice. Objective To explore the motivations for screening-eligible patients to screen for lung cancer. Methods Semi-structured qualitative interviews were conducted with 20 LDCT screen-completed men and women who were members of an integrated mixed-model healthcare system in Washington State. From June to September 2015, participants were recruited and individual interviews performed about motivations to screen for lung cancer. Audio-recorded interviews were transcribed and analyzed using inductive content analysis by three investigators. Results Four primary themes emerged as motivations for completing LDCT lung cancer screening: 1) trust in the referring clinician; 2) early-detection benefit; 3) low or limited harm perception; and 4) friends or family with advanced cancer. Conclusion Participants in our study were primarily motivated to screen for lung cancer based on perceived benefit of early-detection, absence of safety concerns, and personal relationships. Our findings provide new insights about patient motivations to screen, and can potentially be used to improve lung cancer screening uptake and shared decision-making processes.

UR - http://www.scopus.com/inward/record.url?scp=85049510582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049510582&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0196758

DO - 10.1371/journal.pone.0196758

M3 - Article

C2 - 29975709

AN - SCOPUS:85049510582

VL - 13

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e0196758

ER -